ÐÜÈ¥Ñõµ¨ËὺÄÒÈËÌåÉúÎïµÈЧÐÔÑо¿
·¢²¼Ê±¼ä£º
2022-10-17
À´Ô´£º
Å·²©¼¯ÍÅÉúÎï“ҽѧÑо¿×¨À¸”
Ö¼ÔÚΪÁÙ´²Ò½Ñ§Ñо¿ÌṩѧÊõ½»Á÷ƽ̨
·ÖÏí¸öÈËÁÙ´²¿ÆÑоÑé
²»¶¨ÆÚ¿ªÕ¹ÏßÉϿγÌ
Óë¸÷λͬµÀÇд轻Á÷ ̽ÌÖÐÂÖª

×÷Õß | ÐìÏè±ó
У¶Ô | ÍõÐÀÍ© ³Â½à
Ò»¡¢±³¾°
ÐÜÈ¥Ñõµ¨ËᣨUrsodeoxycholic acid£¬UDCA£©×÷Ϊµ¨½áʯºÍµ¨ÖÓÙ»ýÐÔ¸ÎÓ²»¯µÈ¼²²¡µÄ³£ÓÃÅ·²©¼¯ÍŹÙÍø£¬¾ßÓÐÀûµ¨¡¢±£¸Î¡¢½µÌÇ¡¢½µÖ¬ºÍÃâÒßµ÷½ÚµÈÖØÒªÌØÐÔ¡£ÖÐÅ·²©¼¯ÍŹÙÍøÑ§¼ÒºÍ´«Í³ÖÐÒ½Ê״ν«UDCAÓÃÓÚÖÎÁƸÎÔ༲²¡µÄÀúÊ·¿ÉÒÔ×·Ëݵ½Ò»Ç§¶àÄêǰ¡£ÔÚ·¢ÏÖÆä¾ßÓÐÈܽ⵨½áʯµÄ¹¦Ð§Ö®Ç°£¬ÆäÖ÷ÒªÓÃ;ÊÇ×÷Ϊ¸ÎÔಹƷ¡£2004Äê07Ô£¬ÃÀ¹úʳƷŷ²©¼¯ÍŹÙÍøÆ·¼à¶½¹ÜÀí¾Ö£¨FDA£©Åú×¼AxcanÖÆÅ·²©¼¯ÍŹÙÍø¹«Ë¾Éú²úÐÜÈ¥Ñõµ¨ËáÆ¬¼Á£¨500 mg£©ÖÎÁÆÔ·¢ÐÔµ¨ÖÓÙ»ýÐÔ¸ÎÓ²»¯£¨PBC£©¡£¸ÃÅ·²©¼¯ÍŹÙÍøÊÇĿǰΨһ±»ÃÀ¹úFDAÅú×¼ÖÎÁÆPBCµÄÅ·²©¼¯ÍŹÙÍøÎï¡£¼¸Ê®ÄêÀ´µÄÁÙ´²Ñо¿±íÃ÷£¬UDCA³ý¾ßÓÐÀûµ¨¡¢¿¹µòÍö¡¢¿¹Ñõ»¯£¬»¹¾ßÓнµÑªÖ¬ºÍÃâÒßµ÷½ÚµÈÅ·²©¼¯ÍŹÙÍøÀí×÷Óá£UDCAͨ¹ý¶àÖÖ¸´ÔӺͻ¥²¹µÄ»úÖÆ×÷ÓÃÓÚ¸ÎÔ࣬°üÀ¨¸Ä±äµ¨ÖËá³Ø¡¢×÷Ϊϸ°û±£»¤¼Á¡¢ÃâÒßµ÷½ÚÎïÖʺÍÇ×Ë®ÐÔµ¨ÖË᣻´ËÍ⣬ͨ¹ýÒÖÖÆ³¦ÄÚµ¨¹Ì´¼µÄÎüÊպͽµµÍµ¨Ö¬Öе¨¹Ì´¼º¬Á¿Ê¹µ¨¹Ì´¼·ÖÃÚÈ뵨ּõÉÙ£¬´Ó¶øÏÔÖø½µµÍµ¨ÖÖе¨¹Ì´¼±¥ºÍ¶È[1]¡£
ÐÜÈ¥Ñõµ¨ËὺÄÒ£¨ÉÌÆ·Ãû£ºUrsofalk®£©·Ö±ðÓÚ1978ÄêÓë1994ÄêÔڵ¹úºÍÖйú»ñÅúÉÏÊУ¬ÏÖÖ÷ÒªÓÃÓÚµ¨ÄÒÊÕËõ¹¦ÄÜÕý³£¡¢XÉäÏßÄÜ´©Í¸½áʯµÄµ¨¹Ì´¼ÐÔµ¨ÄÒ½áʯ¡¢µ¨ÖÓÙ»ýÐԸβ¡ºÍµ¨Ö·µÁ÷ÐÔθÑ×µÄÖÎÁÆ¡£
±¾ÎĽ«½áºÏÏà¹ØÖ¸µ¼ÔÔòºÍÎÄÏ×Ñо¿£¬Ïêϸ²ûÊöÐÜÈ¥Ñõµ¨ËὺÄÒÈËÌåÉúÎïµÈЧÐÔÊÔÑéµÄÒ»°ã¿¼ÂÇ£¬¶Ô±¾Æ·ÈËÌåÉúÎïµÈЧÐÔÑо¿µÄÈô¸É¹Ø¼üÉè¼Æ½øÐÐ̽ÌÖ£¬Ö¼ÔÚΪ´ËÀà²úÆ·µÄ·ÂÖÆºÍ×¢²áÉ걨Ìṩ²Î¿¼¡£
¶þ¡¢Æ·ÖÖ»ù±¾Çé¿ö
ͨÓÃÃû³Æ£ºÐÜÈ¥Ñõµ¨ËὺÄÒ
ÉÌÆ·Ãû³Æ£ºUrsofalk®/ÓÅ˼¸¥®
Ó¢ÎÄÃû³Æ£ºUrsodeoxycholic Acid Capsules
»¯Ñ§½á¹¹Ê½£º

¹æ¸ñ£º250 mg
ÊÊÓ¦Ö¢£º
1.µ¨ÄÒµ¨¹Ì´¼½áʯ£º±ØÐëÊÇXÉäÏßÄÜ´©Í¸µÄ½áʯ£¬Í¬Ê±µ¨ÄÒÊÕËõ¹¦ÄÜÐëÕý³££»
2.µ¨ÖÓÙ»ýÐԸβ¡£¨È磺Է¢ÐÔµ¨ÖÐÔ¸ÎÓ²»¯£©£»
3.µ¨Ö·´Á÷ÐÔθÑס£
Ó÷¨ÓÃÁ¿£º
1.µ¨ÄÒµ¨¹Ì´¼½áʯºÍµ¨ÖÓÙ»ýÐԸβ¡
°´Ê±ÓÃÉÙÁ¿Ë®ËÍ·þ¡£°´ÌåÖØÃ¿ÈÕ¼ÁÁ¿Îª10 mg/kg£¬¼´£º

ÈÜʯÖÎÁÆ£ºÒ»°ãÐè6~24¸öÔ£¬·þÓÃ12¸öÔºó½áʯδ¼û±äСÕߣ¬Í£Ö¹·þÓá£ÖÎÁƽá¹û¸ù¾Ýÿ6¸öÔ½øÐг¬Éù²¨»òXÉäÏß¼ì²éÅжϡ£
2.µ¨Ö·´Á÷ÐÔθÑ×
ÍíÉÏ˯ǰÓÃË®ÍÌ·þ£¬±ØÐ붨ÆÚ·þÓã¬Ò»´ÎÒ»Á££¨250 mg£©£¬Ò»ÈÕÒ»´Î¡£Ò»°ã·þÓÃ10~14Ì죬×ñ´ÓÒ½Öö¾ö¶¨ÊÇ·ñ¼ÌÐø·þÅ·²©¼¯ÍŹÙÍø¡£
Èý¡¢Àí»¯ÐÔÖÊ¡¢´¦·½ÓëÈܳöÇé¿ö
1¡¢Àí»¯ÐÔÖÊ

ÈܳöÇé¿ö£ºÐÜÈ¥Ñõµ¨ËὺÄÒÊôÓÚBCS¢òÀàÅ·²©¼¯ÍŹÙÍøÎÈܽâÐÔΪÆäÔÚÌåÄÚÎüÊÕµÄÏÞËÙ²½Ö裬¸ù¾ÝÏà¹ØÎÄÏ×Ñо¿[4]¶ÔÔÑÐÖÆ¼ÁÈܳöµÄ¿¼²ì£¬ÐÜÈ¥Ñõµ¨ËὺÄÒÔÚ¸÷pH½éÖÊÖеÄÈܽâÐÔÈçÏ£º


´ÓÉÏÊöÈܳöÇúÏß¿ÉÖª£¬ÐÜÈ¥Ñõµ¨ËὺÄÒÔÚ¸÷¸ö½éÖÊÖÐÈܳöÔÚ30 minʱÈÔµÍÓÚ80%£¬ÇÒ½éÖÊpHÔ½¸ßÈܳöÔ½¿ì£¬ÊôÓÚPHÒÀÀµÐÔÅ·²©¼¯ÍŹÙÍøÎï¡£ÔÑÐ˵Ã÷ÊéÖÐÌáʾ¿Õ¸¹×´Ì¬ÏÂÐÜÈ¥Ñõµ¨ËὺÄÒÔÚ1СʱºÍ3СʱÁ½´Î³öÏÖ·åŨ¶È£¬Òò´ËpH1.2¡¢pH4.5¡¢pH6.0¾ùΪÆäÌåÍâÈܳö¿¼²ì½ÏΪ¹Ø¼üµÄÈܳöÌõ¼þ¡£
ÐÜÈ¥Ñõµ¨ËáÊÇתÔ˵°°×ABCB11¡¢SLCO1A2ÓëSLC10A1µÄµ×ÎÕâÈý¸öתÔ˵°°×Ö÷Òª·Ö²¼ÔÚ¸ÎÔ༰µ¨µÀ¡£¶ÔÓÚµÍÈܸßÉøµÄÅ·²©¼¯ÍŹÙÍøÎÐèÖØµã¹Ø×¢¸¨Á϶ÔÓÚÅ·²©¼¯ÍŹÙÍøÎïÈܽâµÄÓ°Ï죬ÔÚÅ·²©¼¯ÍŹÙÍøÑ§¿ª·¢½×¶ÎÐèÖØµã¹Ø×¢ÊÜÊÔÖÆ¼ÁºÍ²Î±ÈÖÆ¼ÁÔÚ¸¨ÁϳɷֵÄÐͺźͺ¬Á¿µÄÒ»ÖÂÐÔ¡£
ËÄ¡¢ÉúÎïµÈЧÐÔÆÀ¼Û
FDA£¨²Ý°¸£©[5]£ºµ¥¼ÁÁ¿£¨300 mg×2£©¡¢2*2½»²æÌåÄÚÑо¿£¨¿Õ¸¹+²Íºó£©£¬²â¶¨Ñª½¬ÖзǽáºÏÐÜÈ¥Ñõµ¨ËáºÍ×ÜÐÜÈ¥Ñõµ¨Ëᣨ·Ç½áºÏÐÜÈ¥Ñõµ¨Ëá+ÐÜÈ¥Ñõµ¨Ëá¸Ê°±Ëá½áºÏÎï+Å£»ÇËá½áºÏÎ£¬BEÆÀ¼ÛÎïÖÊ»ùÏßУÕýǰ¼°»ùÏßУÕýºóµÄ·Ç½áºÏÐÜÈ¥Ñõµ¨ËáºÍ×ÜÐÜÈ¥Ñõµ¨Ëᣬ²âÁ¿¸øÅ·²©¼¯ÍŹÙÍøÇ°-48¡¢-42¡¢-36¡¢-30¡¢-24¡¢-18¡¢-12¡¢-6¡¢0 hÌåÄÚ»ùÏßÖµ£¬Èô»ùÏßÎȶ¨£¬¿ÉÒÔ½«»ùÏß²ÉÑùʱ¼äËõ¶Ìµ½-24~0 h£¬Ó¦ÒÔ»ùÏßÆÚÆ½¾ùŨ¶È½øÐÐУÕý, УÕýºóµÄŨ¶ÈÈôΪ¸ºÖµÔò¼ÆÎªÁã¡£¶ÔÓڲͺó×飬ӦÔÚ²âÁ¿¸øÅ·²©¼¯ÍŹÙÍø-48¡¢-24¡¢0 h»ùÏßֵǰ30·ÖÖÓÄÚÊÜÊÔÕß½øÊ³Íê±ê×¼¸ßÖ¬²Í¡£
EMA[6]£ºµ¥¼ÁÁ¿£¨250 mg£©¡¢2*2½»²æ£¨¿Õ¸¹£©£¬²â¶¨Ñª½¬ÖзǽáºÏÐÜÈ¥Ñõµ¨Ëᣨ¸øÅ·²©¼¯ÍŹÙÍøÇ°Ò»Ìì²â¶¨»ùÏßÖµ£©£¬BEÆÀ¼ÛÎïÖÊ»ùÏßУÕýºóµÄ·Ç½áºÏÐÜÈ¥Ñõµ¨Ëᣬ²â¶¨¸øÅ·²©¼¯ÍŹÙÍøÇ°24Сʱ»ùÏßÖµ²¢Ð£Õý£¨Óë¸øÅ·²©¼¯ÍŹÙÍøµ±Ìì±£³ÖÏàͬµÄ±ê×¼²Í¼°ÏàÓ¦µÄ²ÉѪµã£©¡£
CDE[7]£ºµ¥¼ÁÁ¿£¨250 mg×2£©¡¢Æ½ÐÐÉè¼Æ»ò2*2½»²æÌåÄÚÑо¿£¨¿Õ¸¹+²Íºó£©£¬²â¶¨Ñª½¬ÖзǽáºÏÐÜÈ¥Ñõµ¨ËáºÍ×ÜÐÜÈ¥Ñõµ¨Ëᣨ·Ç½áºÏÐÜÈ¥Ñõµ¨Ëá+ÐÜÈ¥Ñõµ¨Ëá¸Ê°±Ëá½áºÏÎï+Å£»ÇËá½áºÏÎ£¬BEÆÀ¼ÛÎïÖÊ»ùÏßУÕýºóµÄ·Ç½áºÏÐÜÈ¥Ñõµ¨ËáºÍ×ÜÐÜÈ¥Ñõµ¨Ëᣬ²âÁ¿¸øÅ·²©¼¯ÍŹÙÍøÇ°-48¡¢-42¡¢-36¡¢-30¡¢-24¡¢-18¡¢-12¡¢-6¡¢0 hÌåÄÚ»ùÏßÖµ£¬Èô»ùÏßÎȶ¨£¬¿Éѡȡ¸øÅ·²©¼¯ÍŹÙÍøÇ°-24 h~0 hµÄÊý¾Ý½øÐлùÏßУÕý¡£Ã¿¸öÊÜÊÔÕß»ùÏßУÕýʱӦʹÓø÷×Ô¶ÔÓ¦ÖÜÆÚ»ùÏßˮƽµÄƽ¾ùÖµ¡£ÊÔÑ鲻ͬÖÜÆÚ¼äµÄ»ùÏßÆÚºÍ¸øÅ·²©¼¯ÍŹÙÍøÆÚÊÜÊÔÕß½ø²Í±ê×¼ºÍʱ¼äÓ¦±£³ÖÒ»Ö¡£¶ÔÓڲͺó×飬ӦÔÚ²âÁ¿¸øÅ·²©¼¯ÍŹÙÍø-48¡¢-24¡¢0 h»ùÏßֵǰ30·ÖÖÓÄÚ½øÊ³ÍêÏàͬ±ê×¼²Í£¬²ÉѪÖÕµãѡȡ72 h¡£
1¡¢Ñо¿ÀàÐÍ
FDAºÍCDE¸öÅ·²©¼¯ÍŹÙÍøÖ¸µ¼ÔÔòÍÆ¼öÁ½ÐòÁС¢Á½ÖÜÆÚ½»²æÊÔÑéµÄÉè¼Æ£¬¿ªÕ¹µ¥´Î¸øÅ·²©¼¯ÍŹÙÍøµÄ¿Õ¸¹¼°²ÍºóÈËÌåÉúÎïµÈЧÐÔÑо¿¡£
¸ù¾ÝÏà¹ØÎÄÏ×[8-9]Ñо¿¿ÉÖª£¬¾Ð£×¼ºóÐÜÈ¥Ñõµ¨ËὺÄÒCmax¸öÌåÄÚ±äÒìΪ24.4%~34.8%£¬AUCµÄ¸öÌåÄÚ±äÒìԼΪ1.04%~21.7%×óÓÒ£¬Ìáʾ±¾Æ·¸öÌåÄÚ±äÒ첨¶¯´ó£¬ÇÒÔÑÐ˵Ã÷ÊéÏÔʾ×ÜÐÜÈ¥Ñõµ¨Ëá°ëË¥ÆÚt1/2Ϊ3.5~5.8Ì죬¿¼ÂÇÇåÏ´ÆÚÉè¼ÆºÍÊÜÊÔÕßÒÀ´ÓÐÔ£¬½¨Òé²ÉÓÃÁ½ÖÜÆÚµÄ½»²æÉè¼Æ¡£


2¡¢ÑªÑù²É¼¯
¸ù¾ÝÔÑÐ˵Ã÷Êé¿ÉÖª£¬¿Ú·þ¸øÅ·²©¼¯ÍŹÙÍøºóÐÜÈ¥Ñõµ¨Ëá1Сʱ´ïµ½Ñª½¬·åŨ¶È£¬µÚ¶þ¸ö·åŨ¶ÈÔÚ3Сʱ£¬Æä°ëË¥ÆÚΪ3.5~5.8Ì죬ÔÑÐ×ÊÁÏÒÔ¼°ÎÄÏ×Ñо¿ÖÐÅ·²©¼¯ÍŹÙÍø´ú¶¯Á¦Ñ§²ÎÊýÈçÏ£º

×¢£º[3]ΪÔÑÐ×ÊÁÏ£¬[8]~[11]ΪÎÄÏ×Ñо¿¡£
¸ù¾ÝÉÏÊöPK²ÎÊý£¬BEÑо¿²ÉѪµãÉè¼ÆÊ±Ðè¹Ø×¢´ï·åʱ¼ä·¶Î§ÒÔ¼°°ëË¥ÆÚ£¬¿ÆÑ§µØÉè¼Æ²ÉѪµãÒÔÂú×ãÉúÎïµÈЧÐÔÑо¿µÄÐèÒª¡£¸ù¾ÝÔÑÐÏà¹Ø×ÊÁϺÍÎÄÏ×Êý¾Ý£¬·Ç½áºÏÐÜÈ¥Ñõµ¨ËáºÍ×ÜÐÜÈ¥Ñõµ¨Ëá¿Õ¸¹µÄTmaxÖÐλֵ¼¯ÖÐÔÚ1.0~3.78 h£¬¼«Öµ·¶Î§Îª0.5~6.0 h£¬Òò´Ë¿ÉÔڸôï·å·¶Î§ÄÚ¿ÆÑ§µÄÉè¼Æ²ÉѪµã£»×ÜÐÜÈ¥Ñõµ¨Ëá°ëË¥ÆÚt1/2Ϊ3.5~5.8Ì죬Ϊ³¤°ëË¥ÆÚÅ·²©¼¯ÍŹÙÍøÎ¸ù¾Ý¡¶ÒÔÅ·²©¼¯ÍŹÙÍø¶¯Ñ§²ÎÊýΪÖÕµãÆÀ¼ÛÖ¸±êµÄ»¯Ñ§Å·²©¼¯ÍŹÙÍøÎï·ÂÖÆÅ·²©¼¯ÍŹÙÍøÈËÌåÉúÎïµÈЧÐÔÊÔÑéÖ¸µ¼ÔÔò¡·Óë¡¶ÐÜÈ¥Ñõµ¨ËὺÄÒÉúÎïµÈЧÐÔÑо¿¼¼ÊõÖ¸µ¼ÔÔò¡·£¬±¾Æ·Ïû³ý°ëË¥ÆÚ½Ï³¤ÇÒ´æÔÚ³¦¸ÎÑ»·£¬¿ÉÄܵ¼ÖÂÄ©¶ËÏû³ýÏನ¶¯£¬´Ó¶øÓ°ÏìAUC0-∞¹ÀËãµÄ¿É¿¿ÐÔ£¬´Ëʱ¿É²ÉÓÃCmaxºÍAUC0-tΪÆÀ¼Û¶ÔÏ󣬲ÉѪÖÕµã½ØÈ¡µ½¸øÅ·²©¼¯ÍŹÙÍøºó72 h£¬Òò´Ë²ÉѪÖÕµã¿ÉÉ趨Ϊ72 h¡£
ĿǰÎÞÑо¿±íÃ÷Ѫ½¬ÖзǽáºÏÐÜÈ¥Ñõµ¨ËáºÍ×ÜÐÜÈ¥Ñõµ¨ËáÔÚÖйúÈËȺÌåÄÚ»ùÏßÖµÎȶ¨£¬¹Ê²Î¿¼CDE·¢²¼µÄ¡¶ÐÜÈ¥Ñõµ¨ËὺÄÒÉúÎïµÈЧÐÔÑо¿¼¼ÊõÖ¸µ¼ÔÔò¡·£¬²âÁ¿¸øÅ·²©¼¯ÍŹÙÍøÇ°-48¡¢-42¡¢-36¡¢-30¡¢-24¡¢-18¡¢-12¡¢-6¡¢0 hÌåÄÚ»ùÏßÖµ£¬Ã¿¸öÊÜÊÔÕß»ùÏßУÕýʱʹÓø÷×Ô¶ÔÓ¦ÖÜÆÚ»ùÏßˮƽµÄƽ¾ùÖµ¡£
3¡¢¼ì²âÎïÖÊ
¸ù¾Ý¡¶ÒÔÅ·²©¼¯ÍŹÙÍø¶¯Ñ§²ÎÊýΪÖÕµãÆÀ¼ÛÖ¸±êµÄ»¯Ñ§Å·²©¼¯ÍŹÙÍøÎï·ÂÖÆÅ·²©¼¯ÍŹÙÍøÈËÌåÉúÎïµÈЧÐÔÊÔÑéÖ¸µ¼ÔÔò¡·£¬Ò»°ãÍÆ¼ö½ö²â¶¨ÔÐÎÅ·²©¼¯ÍŹÙÍøÎ¶ÔÓÚ´ÓÔÐÎÅ·²©¼¯ÍŹÙÍøÎïÖ±½Ó´úл²úÉúµÄÖ÷Òª´úл²úÎµ±´úл²úÎïÖ÷Òª²úÉúÓÚ½øÈëÌåÑ»·ÒÔǰ£¬²¢ÇÒ´úл²úÎïÏÔÖøÓ°ÏìÅ·²©¼¯ÍŹÙÍøÎïµÄ°²È«ÐÔºÍÓÐЧÐÔʱ£¬Ó¦²â¶¨¸Ã´úл²úÎï¡£

×÷ΪһÖÖÄÚÔ´ÐÔµ¨ÖËᣬUDCA¾ßÓзdz£¶ÀÌØµÄADMEÌØÕ÷¡£ÈçÉÏͼËùʾ£¬¾ßÌå±íÏÖΪÍù¸´µÄ¸Î-µ¨-³¦Ñ»·´¦Öùý³Ì¼°ÆäÖй㷺µÄËÞÖ÷-³¦µÀ¾úȺ¹²´úл£¬Óɴ˵¼ÖÂÆäÖ÷ÒªÐî»ýÔÚ¸Î-µ¨-³¦¹¹³ÉµÄµ¨ÖËá³ØÖС£×îÖÕÖ÷ÒªÓɳ¦µÀ¾úȺ´úлΪ²»ÈÜÓÚË®µÄʯµ¨Ëᣨlithocholic acid£¬LCA£©Í¨¹ý·à±ãÅÅй[12]¡£
UDCAÔÚÌåÄÚµÄÖ÷Òª´æÔڵĻîÐÔÐÎʽÊÇÐÜÈ¥Ñõµ¨Ëá¸Ê°±Ëá½áºÏÎGUDCA£©ºÍÅ£»ÇËá½áºÏÎTUDCA£©£¬Í¬Ê±FDAÓëCDE¸öÅ·²©¼¯ÍŹÙÍøÖ¸µ¼ÔÔòÍÆ¼ö¶ÔѪ½¬ÖеÄÓÎÀëUDCAºÍ×ÜUDCAµÄѪŷ²©¼¯ÍŹÙÍøÅ¨¶È½øÐвâÁ¿ÒÔ½øÐÐÉúÎïµÈЧÐÔÆÀ¼Û·ÖÎö£¬Òò´Ë±¾Æ·ÉúÎïµÈЧÐÔÑо¿Öеļì²âÎïÖÊΪѪ½¬ÖеÄÓÎÀëUDCAºÍ×ÜUDCA¡£
4¡¢ÉúÎïµÈЧÐÔÆÀ¼Û
ÓÉÓÚÄÚÔ´ÐÔUDCAµÄºÏ³ÉºÍ´úлÇå³ýËÙÂÊÊܳ¦µÀ¾úȺºÍËÞÖ÷µÄ´úлˮƽÒÔ¼°ÒûʳµÄ×ÛºÏÓ°Ï죬´æÔÚËæÒûʳ½ÚÂɲ¨¶¯µÄ»ùÏß±³¾°£¬Òò´ËӦʹÓûùÏßУÕýºóµÄѪ½¬ÖеÄÓÎÀëUDCAºÍ×ÜUDCAµÄPK²ÎÊýÀ´ÆÀ¹ÀÉúÎïµÈЧÐÔ¡£
±¾Æ·Ïû³ý°ëË¥ÆÚ½Ï³¤ÇÒ´æÔÚ³¦¸ÎÑ»·£¬¿ÉÄܵ¼ÖÂÄ©¶ËÏû³ýÏನ¶¯£¬´Ó¶øÓ°ÏìAUC0-∞¹ÀËãµÄ¿É¿¿ÐÔ£¬¿É²ÉÓÃCmaxºÍAUC0-tΪÆÀ¼Û¶ÔÏó£¬ÉúÎïµÈЧÐÔ½ÓÊܱê׼ΪÊÜÊÔÖÆ¼ÁÏà±È²Î±ÈÖÆ¼ÁµÄCmaxºÍAUC0-tµÄ¼¸ºÎ¾ùÖµ±È90%ÖÃÐÅÇø¼äÔÚ80.00%~125.00%·¶Î§ÄÚ¡£
5¡¢¹úÄÚÉ걨Çé¿ö·ÖÎö
ÔÑÐ1994Äê04ÔÂ17ÈÕÓÚ¹úÄÚÊ״λñµÃÅú×¼ÉÏÊУ¬Ä¿Ç°°²Ê¿ÖÆÅ·²©¼¯ÍŹÙÍø£¨ÖÐɽ£©ÓÐÏÞ¹«Ë¾¡¢ÉϺ£Ðû̩ҽŷ²©¼¯ÍŹÙÍø¿Æ¼¼¹É·ÝÓÐÏÞ¹«Ë¾ºÍ³É¶¼ÈüZÉúÎïҽŷ²©¼¯ÍŹÙÍø¿Æ¼¼ÓÐÏÞ¹«Ë¾ÏȺóÒÔ»¯Å·²©¼¯ÍŹÙÍø4À౨²ú¸ÃÅ·²©¼¯ÍŹÙÍø²¢ÊÓͬͨ¹ýÒ»ÖÂÐÔÆÀ¼Û£¬ÁíÓÐ3¼Ò°´ÕÕ»¯Å·²©¼¯ÍŹÙÍø4ÀàÒÑÌá½»É걨×ÊÁÏ£¬Êг¡¿Éν¾ºÕù¼¤ÁÒ¡£
×ۺϷÖÎöĿǰ¸ÃÆ·ÖÖÔÚCDEµÇ¼ÇµÄÁÙ´²ÊÔÑéÐÅÏ¢£¬ËùÓÐÉ걨Éú²úµÄÆóÒµ¿Õ¸¹ºÍ²ÍºóÊÔÑé¾ù²ÉÓÃÁ½ÖÜÆÚ¡¢Á½ÐòÁн»²æÉè¼Æ£¬Ñù±¾Á¿Îª52~160Àý²»µÈ£¬Ìáʾ±¾Æ·BEÊÔÑéÑù±¾Á¿ÓëÁ½ÖƼÁ¼ä²îÒì¡¢¸öÌåÄÚ±äÒì¼°ÁÙ´²ÊÔÑé¹ý³ÌÖеĻùÏßÓ°ÏìÒòËØµÄ¹ÜÀíÏà¹Ø£¬¿ªÕ¹ÌåÄÚBEÑо¿Ç°Ó¦³ä·ÖÆÀ¹ÀÖÆ¼Á²îÒ죬ÁÙ´²ÊÔÑé¹ý³ÌÖÐӦע֨¸öÌåÄÚ±äÒì¿ØÖÆ£¬Ìá¸ßÁÙ´²ÊÔÑéÖÊÁ¿¡£
Îå¡¢×ܽá
UDCAÔڸβ¡ÖÎÁÆÁìÓò¾ßÓÐÖØÒªµØÎ»£¬µ«ÊÇ×÷ΪһÖÖÄÚÔ´ÐÔÅ·²©¼¯ÍŹÙÍøÎÆäÔÚÈËÌåÄÚ¾ßÓнϸ´ÔӵĴúл¹ý³Ì£¬·ÂÖÆÅ·²©¼¯ÍŹÙÍøÑз¢¾ßÓнϸߵļ¼ÊõÌôÕ½£¬°üÀ¨³¤°ëË¥ÆÚ¡¢¸Î³¦Ñ»·¡¢´úлÎïת»¯µÈÎÊÌ⣬ÐèÌØ±ð¹Ø×¢ÊÔÑéÉè¼Æ¼°ÁÙ´²ÊÔÑé¹ý³ÌÖеÄÁÙ´²¹Ü¿Ø¡£
±¾ÎÄ×ܽáÁËUDCAÉúÎïµÈЧÐÔÑо¿µÄÏÖ×´£¬½áºÏÏÖÓÐÏà¹ØBE¼¼ÊõÖ¸ÄÏ¡¢Ñо¿ÏÖ×´ºÍ¹Ø¼ü¼¼ÊõÌôÕ½£¬ÆÚÍûΪUDCA·ÂÖÆÅ·²©¼¯ÍŹÙÍøÑз¢BEÊÔÑéµÄ¼¼Êõ¹¥¹ØÌṩÓмÛÖµµÄ²Î¿¼¡£
ÎÒ˾ӵÓзḻµÄÄÚÔ´ÐÔÅ·²©¼¯ÍŹÙÍøÎï¼°´æÔÚÌåÄÚ´úлת»¯µÄBEÏîÄ¿¾Ñ飬ÆäÖÐÄÚÔ´ÐÔÎïÖʰüÀ¨¶¡¶þ»ÇËáÏÙÜÕµ°°±Ëá¡¢»ÆÌåͪÒõµÀ»ºÊÍÄý½º¡¢ÒÒõ£°ëë×°±Ëá¿ÅÁ£¼°ÅÝÌÚÆ¬µÈ£¬ÒÔ¼°ÒÀÕÛÂ󲼯¬µÈ´æÔÚ¸´ÔÓÌåÄÚ´úл¹ý³ÌµÄÅ·²©¼¯ÍŹÙÍøÎï¡£ÎÒ˾ÖÂÁ¦ÓÚ°ïÖúÖÚ¶àÉê°ìÕß½øÐи´ÔÓÏîÄ¿µÄÁÙ´²ÆÀ¼Û£¬ÖúÁ¦Ò½Å·²©¼¯ÍŹÙÍøÑз¢¡£
Áù¡¢²Î¿¼ÎÄÏ×
[1]ÓÈ÷¹ð.ÐÜÈ¥Ñõµ¨ËáµÄÑо¿¸Å¿ö[J].Å·²©¼¯ÍŹÙÍøÑ§Ñо¿,2021,40(03):199-202.DOI:10.13506/j.cnki.jpr.2021.03.013.
[2]Çñ¿ÆÏÈ.×ÔÖÆÐÜÈ¥Ñõµ¨ËὺÄÒÓë²Î±ÈÖÆ¼ÁÌåÍâÈܳöÒ»ÖÂÐÔÆÀ¼ÛÑо¿[J].¹ã¶«»¯¹¤,2021,48(16):72-73+91.
[3]UrsofalkÔÑÐ˵Ã÷Ê飨°Ä´óÀûÑÇ£©
[4]¶¡Ù»,ÌÆÁø.5ÖÖ·ÛË鹤ÒÕ¶ÔÐÜÈ¥Ñõµ¨ËὺÄÒÌåÍâÈܳöµÄÓ°Ïì[J].ÖйúÅ·²©¼¯ÍŹÙÍøÑ§ÔÓÖ¾,2016,51(23):2037-2040.
[5]U.S.Food and Drug Administration.Draft Guidance on Ursodiol.2021.
[6]European Medicines Agency.Ursodeoxycholic acid product-specific bioequivalence guidance.2021.
[7]¹ú¼ÒÅ·²©¼¯ÍŹÙÍøÆ·¼à¶½¹ÜÀí¾ÖÅ·²©¼¯ÍŹÙÍøÆ·ÉóÆÀÖÐÐÄ.ÐÜÈ¥Ñõµ¨ËὺÄÒÉúÎïµÈЧÐÔÑо¿¼¼ÊõÖ¸µ¼ÔÔò.2021.
[8]Ursodeoxycholzuur Strides 250 mg,capsules,hard Strides Arcolab International Ltd.,United Kingdom(Public Assessment Report)
[9]Grinterol 250 mg hard capsules(Public Assessment Report)
[10]Ursosan 250 mg hard capsules(Public Assessment Report)
[11]ÑÕÒ«¶«,ÑîÖÒÃñ,»ÆÏþ½à,лÄþ,ÕÅΰ.ÐÜÈ¥Ñõµ¨ËὺÄÒÈËÌåÉúÎïµÈЧÐÔÑо¿[J].ÖйúÅ·²©¼¯ÍŹÙÍøÑ§ÔÓÖ¾,2008(03)213-217.
[12]¶¡¾¢ËÉ,Íõ°²ÄÈ,»ÆÁÁ,¼Öΰ,Áõ²ýТ,À¼éð.ÈËÌåÐÜÈ¥Ñõµ¨Ëá´úл¼°ÆäÉúÎïµÈЧÐÔÑо¿µÄ¼¼ÊõÌôÕ½[J].Å·²©¼¯ÍŹÙÍøÑ§Ñ§±¨,2020,55(09)2070-2079.DOI10.16438j.0513-4870.2020-0447.
¶÷¸ñÁо»Æ¬ÈËÌåÉúÎïµÈЧÐÔÑо¿·ÖÎö
ÏÂÒ»Ò³
ÏÂÒ»Ò³
¶÷¸ñÁо»Æ¬ÈËÌåÉúÎïµÈЧÐÔÑо¿·ÖÎö